(Q73088305)

English

Chimeric monoclonal anti-CD20 antibody (rituximab)--an effective treatment for a patient with relapsing hairy cell leukaemia

scientific article published on 01 September 1999

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10523804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10523804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 November 2019

title

Chimeric monoclonal anti-CD20 antibody (rituximab)--an effective treatment for a patient with relapsing hairy cell leukaemia (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10523804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10523804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 November 2019

author name string

H Hagberg

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10523804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10523804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 November 2019

publication date

1 September 1999

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10523804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10523804%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

10523804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10523804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 November 2019

volume

16

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10523804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10523804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 November 2019

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10523804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10523804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 November 2019

page(s)

221-222

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10523804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10523804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 November 2019

exact match

https://scigraph.springernature.com/pub.10.1007/bf02906136

0 references

cites work

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10523804

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10523804

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

(Q73088305)

Chimeric monoclonal anti-CD20 antibody (rituximab)--an effective treatment for a patient with relapsing hairy cell leukaemia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)